HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philippe Rousselot Selected Research

Philippe Rousselot Research Topics

Disease

59BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2024 - 03/2003
15Philadelphia Chromosome
05/2024 - 03/2003
15Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2023 - 07/2002
14Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2024 - 02/2007
12Neoplasms (Cancer)
04/2024 - 05/2003
11Leukemia
01/2019 - 05/2003
8Blast Crisis (Blast Phase)
12/2018 - 03/2003
6Residual Neoplasm
05/2024 - 06/2012
5Hematologic Neoplasms (Hematological Malignancy)
10/2023 - 07/2009
5Myelodysplastic Syndromes (Myelodysplastic Syndrome)
08/2023 - 12/2005
5Acute Promyelocytic Leukemia
01/2023 - 06/2003
5Thrombocytopenia (Thrombopenia)
05/2022 - 02/2011
5Pleural Effusion (Pleural Effusions)
01/2021 - 06/2007
4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
10/2023 - 11/2011
3Eosinophilia
04/2024 - 01/2007
3Neutropenia
01/2016 - 02/2011
2Disease Progression
05/2024 - 06/2006
2Lymphoma (Lymphomas)
01/2022 - 01/2003
2Pulmonary Arterial Hypertension
10/2020 - 01/2016
2Cardiovascular Diseases (Cardiovascular Disease)
02/2016 - 02/2011
2Myeloproliferative Disorders (Myeloproliferative Disorder)
09/2015 - 01/2007
2Polycythemia Vera
09/2006 - 05/2005
1Hypereosinophilic Syndrome (Loeffler Endocarditis)
04/2024
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
05/2022
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022
1Pulmonary Tuberculosis
11/2020
1Interstitial Lung Diseases (Interstitial Lung Disease)
10/2020
1Musculoskeletal Pain
11/2019
1Nausea
12/2018
1Diarrhea
12/2018
1Hypertension (High Blood Pressure)
11/2018
1Chronic Disease (Chronic Diseases)
01/2018
1Lung Neoplasms (Lung Cancer)
01/2018
1Myocardial Infarction
01/2018
1Heart Failure
01/2018
1Kidney Neoplasms (Kidney Cancer)
01/2018
1Hairy Cell Leukemia
01/2018
1Cardiotoxicity
04/2017
1Hodgkin Disease (Hodgkin's Disease)
04/2017

Drug/Important Bio-Agent (IBA)

47Imatinib Mesylate (Gleevec)FDA Link
05/2024 - 03/2003
36Tyrosine Kinase InhibitorsIBA
05/2024 - 11/2003
16Dasatinib (BMS 354825)FDA Link
01/2023 - 04/2007
14Cytarabine (Cytosar-U)FDA LinkGeneric
03/2024 - 07/2002
7ponatinibIBA
05/2024 - 09/2014
6bcr-abl Fusion ProteinsIBA
01/2016 - 03/2003
5Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
04/2024 - 04/2003
5Phosphotransferases (Kinase)IBA
03/2024 - 02/2010
5Oncogene Proteins (Oncogene Protein)IBA
02/2016 - 04/2006
4bosutinibIBA
01/2022 - 01/2017
4Gemtuzumab (Mylotarg)FDA Link
08/2014 - 01/2012
3nilotinibFDA Link
03/2024 - 02/2016
3Biomarkers (Surrogate Marker)IBA
10/2023 - 01/2023
3Azacitidine (5 Azacytidine)FDA Link
10/2023 - 11/2013
3Retinoic Acid Receptor alphaIBA
08/2023 - 11/2003
3Messenger RNA (mRNA)IBA
01/2023 - 01/2022
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2018 - 04/2015
3Asparaginase (Elspar)FDA Link
11/2016 - 04/2015
3Dexamethasone (Maxidex)FDA LinkGeneric
06/2015 - 02/2007
3Daunorubicin (Cerubidine)FDA LinkGeneric
01/2012 - 02/2010
3InterferonsIBA
11/2010 - 03/2003
3Tretinoin (Retinoic Acid)FDA LinkGeneric
05/2010 - 06/2003
3Arsenic Trioxide (Trisenox)FDA Link
12/2008 - 06/2003
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
12/2018 - 01/2015
2Alanine Transaminase (SGPT)IBA
12/2018 - 01/2015
2AnthracyclinesIBA
04/2017 - 02/2010
2Vincristine (Oncovin)FDA LinkGeneric
06/2015 - 02/2007
2Doxorubicin (Adriamycin)FDA LinkGeneric
06/2015 - 02/2011
2Alkylating AgentsIBA
04/2015 - 01/2003
2DNA (Deoxyribonucleic Acid)IBA
04/2015 - 11/2003
2Mitoxantrone (Novantrone)FDA LinkGeneric
04/2015 - 02/2007
2Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
06/2014 - 01/2007
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2007 - 07/2002
2Interferon-alpha (Interferon Alfa)IBA
12/2006 - 03/2003
2VaccinesIBA
04/2006 - 11/2003
1venetoclaxIBA
10/2023
1tamibaroteneIBA
08/2023
1ruxolitinibIBA
01/2023
1Interleukin-7 Receptors (Interleukin 7 Receptor)IBA
01/2023
1src-Family KinasesIBA
01/2023
1gilteritinibIBA
01/2023
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2023
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2023
1COVID-19 VaccinesIBA
05/2022
1mRNA VaccinesIBA
05/2022
1Immunoglobulins (Immunoglobulin)IBA
01/2022
1Prednisone (Sone)FDA LinkGeneric
11/2021
1Proteins (Proteins, Gene)FDA Link
11/2021
1BI 6727IBA
08/2021
1ibrutinibIBA
11/2020
1CoagulantsIBA
11/2018
1Immunotoxins (Immunotoxin)IBA
01/2018
1immunotoxin HA22IBA
01/2018
1NivolumabIBA
01/2018

Therapy/Procedure

29Therapeutics
10/2023 - 03/2003
12Drug Therapy (Chemotherapy)
03/2024 - 01/2003
2Stem Cell Transplantation
01/2018 - 11/2010
1Immunotherapy
05/2024
1Precision Medicine
10/2023
1Injections
05/2022
1Aftercare (After-Treatment)
01/2018